News
Exelixis Inc (EXEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Challenges
Exelixis Inc (EXEL) reports robust financial results driven by the cabozantinib franchise, while navigating competitive and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results